NOVARTIS AG

Forecast & Rating12 analysts currently cover NOVARTIS AG, with about 41.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $154.77, about 0.2% downside from the current price of $155.01. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 63.8% of past price targets were eventually met, which adds credibility. For you, this means institutional views on NOVARTIS AG are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 24, 2026; for reference only and not investment advice.